| Name
|
Amylin (8-37), Amide, Rat
|
| Other Name
|
Amylin (8-37), amide; amylin pharmaceuticals; muraglitazar; oxyntomodulin; symlinDiabetes Associated Peptide (8-37), amide
|
| Sequence (Single letter abbreviations)
|
ATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2
|
| Sequence（Three letter abbreviations）
|
{ALA}{THR}{GLN}{ARG}{LEU}{ALA}{ASN}{PHE}{LEU}{VAL}{ARG}{SER}{SER}{ASN}{ASN}{LEU}{GLY}{PRO}{VAL}{LEU}{PRO}{PRO}{THR}{ASN}{VAL}{GLY}{SER}{ASN}{THR}{TYR}-NH2
|
| C-port
|
NH2
|
| Basic description
|
Amylin is a 37-aa peptide produced in the pancreatic beta-cell secretory granules and Amylin is co-released with insulin. Amylin has specific binding sites in the CNS and Amylin may regulate gastric emptying and influence carbohydrate metabolism.
|
| Solubility
|
Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents.
|
| The molecular weight
|
3200.600
|
| Chemical formula
|
C140H227N43O43
|
| The purity
|
> 95%
|
| Storage conditions
|
Store at -20°C. Keep tightly closed.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
|
Amylin (8-37), Amide, Rat
